BarryS.CollerMD
Hematology • New York, NYClinical Professor, Medicine, Icahn School of Medicine at Mount Sinai
Are you Dr. Coller?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1230 York Ave
Box 309
New York, NY 10065Phone+1 212-327-7490Fax+1 212-327-7493
Summary
- Dr. Barry Coller, MD is a hematologist in New York, New York. He is currently licensed to practice medicine in New York and California. He is affiliated with The Mount Sinai Hospital and is a Clinical Professor at Icahn School of Medicine at Mount Sinai.
Education & Training
New York University School of MedicineClass of 1970, MD
Certifications & Licensure
CA State Medical License 1975 - Present
NY State Medical License 1971 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Pathology Hematology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1999
- Elected Member The American Society for Clinical Investigation, 1980
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders. Start of enrollment: 2005 Sep 01
Publications & Presentations
PubMed
- 23 citationsNovel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations.Jihong Li, Yoshiyuki Fukase, Yi Shang, Wei Zou, José M. Muñoz-Félix
ACS Pharmacology & Translational Science. 2019-08-02 - 156 citationsPlatelet-Active DrugsCarlo Patrono, Barry S. Coller, James E. Dalen, Valentin Fuster, Michael Gent
Chest. 1998-11-01 - 18 citationsPharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elev...W L Bor, Kai L Zheng, Anne H. Tavenier, C. Michael Gibson, Christopher B. Granger
Eurointervention. 2021-08-06
Press Mentions
Large Study Confirms Significant Frequency of Undetected Responsiveness in Severe Brain InjuryAugust 14th, 2024
Persistent Cellular Immunity to SARS-CoV-2 InfectionJanuary 27th, 2021- Mosaic Nanoparticles Elicit Cross-Reactive Immune Responses to Zoonotic Coronaviruses in MiceNovember 17th, 2020
- Join now to see all
Grant Support
- Transforming Translational Science And Education To Benefit Human HealthNational Center For Research Resources2011
- Integrin Alphaiibbeta3 Structure, Activation, And Ligand BindingNational Heart, Lung, And Blood Institute2008–2011
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2006–2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2006–2011
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2006–2011
- Transforming Clinical And Translational Research And Education At RockefellerNational Center For Research Resources2006–2010
- High Throughput Screen For Novel Inhibitors Of Platelet Integrin Alphaiib-Beta3National Institute Of Mental Health2007–2008
- Beta-3 Integrins In Platelet And Vasoocclusive DisordersNational Heart, Lung, And Blood Institute2003–2007
- Ctsa: K12 ComponentNational Center For Research Resources2006
- General Clinical Research CenterNational Center For Research Resources2005–2006
- Studies Of The Interactions Among Normal And Abnormal Blood CellsNational Center For Research Resources2005
- Platelet Leukocyte Interactions In Vascular DiseaseNational Heart, Lung, And Blood Institute2004–2005
- Integrin Biogenesis In Human Es-Derived MegakaryocytesNational Heart, Lung, And Blood Institute2004
- Studies Of The Interactions Among Normal And Abnormal Blood Cells...National Center For Research Resources2004
- Novel On-Line Education In Protection Of Human SubjectsNational Center For Research Resources2003
- Information Technology To Enhance IRB FunctionsNational Center For Research Resources2002
- Platelet Leukocyte Interactions In Vascular DiseaseNational Heart, Lung, And Blood Institute2001–2002
- Biochemistry/Physiology Of Platelet Membrane ReceptorsNational Heart, Lung, And Blood Institute2001–2002
- Biochemistry/Physiology Of Platelet Membrane ReceptorsNational Heart, Lung, And Blood Institute1999–2000
- Antiplatelet Agents As AnticoagulantsNational Heart, Lung, And Blood Institute1996–2000
- Biochemistry/Physiology Of Platelet Membrane ReceptorsNational Heart, Lung, And Blood Institute1997–1998
- Biochemistry/Physiology Of Platelet Membrane ReceptorsNational Heart, Lung, And Blood Institute1993–1996
- Biochemistry/Physiology Of Platelet Membrane ReceptorsNational Heart, Lung, And Blood Institute1989–1992
- Biochemistry/Physiology Of Platelet Membrane ReceptorsNational Heart, Lung, And Blood Institute1985–1988
